Key result
Elevated plasma CHRDL1 linked to ~170% higher incident AMI risk in type 2 diabetes.
Why the study?
Do specific plasma proteins predict incident acute myocardial infarction in Asian adults with type 2 diabetes?
Cohort (n=1,830)
Yes
Do specific plasma proteins predict incident acute myocardial infarction in Asian adults with type 2 diabetes?
Answers are grounded in this paper and cite their sources.
Plasma proteomics, specifically an 8-protein panel, significantly improves risk stratification for incident acute myocardial infarction in Asian patients with type 2 diabetes.
BACKGROUND: Individuals with type 2 diabetes (T2D) have increased risk of acute myocardial infarction (AMI). Cardiovascular risk within T2D is heterogeneous and not fully explained by conventional risk factors, highlighting the need for improved biological risk stratification. OBJECTIVES: The authors aimed to identify circulating proteins associated with incident AMI in T2D, evaluate their incremental predictive value, and explore potential causal relationships. METHODS: In 1,830 adults with T2D from the prospective SMART2D cohort, 1,457 plasma proteins were quantified at baseline using Olink proximity extension assays. Participants were followed for incident AMI through linkage with the Singapore Myocardial Infarction Registry over a median of 10.2 years (IQR: 9.1-10.7). Multivariable Cox regression assessed protein-AMI association. Incremental predictive performance was evaluated using Harrell's C-statistic, likelihood ratio tests (LRTs), net reclassification index (NRI), and integrated discrimination index (IDI). Two-sample Mendelian randomization, using cis-protein qualitative-trait loci from SMART2D and outcome data from Biobank Japan (14,992 cases; 146,214 controls), examined causal associations. RESULTS: ), with the strongest associations observed for NEFL (HR: 1.70, 95% CI: 1.43-2.01), EDA2R (HR: 2.25, 95% CI: 1.69-2.97), and CHRDL1 (HR: 2.69, 95% CI: 1.83-3.94). An 8-protein panel improved risk classification beyond clinical variables (LRT P = 0.002; IDI: 0.049, 95% CI: 0.022-0.128, P = 0.002; and NRI: 0.318, 95% CI: 0.112-0.411, P = 0.008). Genetically predicted plasma FGF5 levels were associated with myocardial infarction risk. CONCLUSIONS: Plasma proteomics improves AMI risk stratification in T2D, and FGF5 may play a role in cardiovascular risk in Asian populations.
No takes yet. Share an insight, caveat, or question.
Gurung et al. (2026) conducted a cohort in Type 2 diabetes (n=1,830). Circulating plasma proteins (e.g., NEFL, EDA2R, CHRDL1) was evaluated on Incident acute myocardial infarction (HR 2.69, 95% CI 1.83-3.94). Specific plasma proteins were strongly associated with incident acute myocardial infarction in type 2 diabetes, with CHRDL1 showing the highest risk.
Synapse has enriched 10 related papers. Consider them for comparative context: